Fabrizio Bossa
San Giovanni Rotondo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
A spatially organized immune-stromal program drives the fissure-to-fistula continuum in Crohn's disease.
Journal: Journal of Crohn's & colitis
Published: July 29, 2026
Rare AFG3L2 and POLG Variants Suggest a Role for Mitochondrial Dysfunction in Enteric Neuronal Vulnerability in Idiopathic Achalasia.
Journal: International journal of molecular sciences
Published: June 16, 2026
Correction: Parente et al. Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience. Diagnostics 2022, 12, 685.
Journal: Diagnostics (Basel, Switzerland)
Published: June 11, 2026
Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 05, 2026
Machine Learning for Colitis-Associated Cancer in Inflammatory Bowel Disease: Evidence and Future Directions Toward Precision Medicine, a Narrative Review.
Journal: International journal of molecular sciences
Published: May 27, 2026
Response to Letter to the Editor: "Enhancing the robustness of early vs late switch to subcutaneous infliximab in inflammatory bowel disease (IBD): the value of propensity score analysis".
Journal: Inflammatory bowel diseases
Published: February 04, 2026
Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: January 28, 2026
Determinants of Telemedicine Satisfaction in Inflammatory Bowel Disease Patients: A Multi-Centre Cross-Sectional Study.
Journal: Medicina (Kaunas, Lithuania)
Published: December 15, 2025
Validation of the Italian-Telemedicine Satisfaction Questionnaire in inflammatory bowel disease patients in Italy.
Journal: Minerva gastroenterology
Published: November 05, 2025
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Journal: The American journal of gastroenterology
Published: October 27, 2025
Reply: "Early Switching to Subcutaneous Infliximab as a Pragmatic Strategy for Optimized Inflammatory Bowel Disease Care".
Journal: Inflammatory bowel diseases
Published: October 08, 2025
Last Updated: 09/26/2026